Detalles de la búsqueda
1.
Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination.
Immunity
; 55(9): 1732-1746.e5, 2022 09 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35961317
2.
Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT.
Blood
; 2024 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38643511
3.
Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study.
Blood
; 141(14): 1675-1684, 2023 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36542826
4.
Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations.
Blood
; 142(10): 865-877, 2023 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37300386
5.
Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation study.
Cancer
; 2024 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38581695
6.
Plain language summary of the TRANSFORM study primary analysis results: lisocabtagene maraleucel as a second treatment regimen for large B-cell lymphoma following failure of the first treatment regimen.
Future Oncol
; 2024 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38547003
7.
Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial.
Lancet
; 399(10343): 2294-2308, 2022 06 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35717989
8.
Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective study by the chronic malignancies working party of the EBMT.
Am J Hematol
; 98(1): 112-121, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36266607
9.
NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals.
Mol Med
; 28(1): 20, 2022 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35135470
10.
Trends in autologous stem cell transplantation for newly diagnosed multiple myeloma: Changing demographics and outcomes in European Society for Blood and Marrow Transplantation centres from 1995 to 2019.
Br J Haematol
; 197(1): 82-96, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35166376
11.
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
N Engl J Med
; 380(1): 45-56, 2019 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30501490
12.
Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study.
Lancet Oncol
; 22(10): 1403-1415, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34516954
13.
Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation.
Haematologica
; 106(2): 363-374, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31879324
14.
Abatacept as salvage therapy in chronic graft-versus-host disease-a retrospective analysis.
Ann Hematol
; 100(3): 779-787, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33515310
15.
Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell Transplantation.
Antimicrob Agents Chemother
; 64(4)2020 03 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32015031
16.
Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE).
Haematologica
; 105(2): 297-316, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31753925
17.
Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT.
Haematologica
; 105(1): 47-58, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31537691
18.
Excretion of Ascaris lumbricoides following reduced-intensity allogeneic hematopoietic stem cell transplantation and consecutive treatment with mebendazole.
Transpl Infect Dis
; 22(1): e13224, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31782899
19.
Allodepleted T-cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft-versus-host disease (GVHD) in the absence of GVHD prophylaxis.
Br J Haematol
; 186(5): 754-766, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31135970
20.
Boost and loss of immune responses against tumor-associated antigens in the course of pregnancy as a model for allogeneic immunotherapy.
Blood
; 125(2): 261-72, 2015 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-25395422